| Peer-Reviewed

Radical Cystectomy in Elderly Patients, Single Center, 25 Years Experience

Received: 11 December 2014    Accepted: 24 December 2014    Published: 31 December 2014
Views:       Downloads:
Abstract

Objectives: To investigate the relation between age and tumor characteristics and to evaluate oncologic results after radical cystectomy in elderly patients. Materials and Methods: We reviewed 501 patients retrospectively who underwent radical cystectomy because of bladder cancer. Patients were divided into two groups; greater than or equal to 70 (group 1) and less than 70-years-old (group 2). We compared tumor pathological characteristics and oncologic results in both groups. American Society of Anesthesiologists (ASA) score is less than three and there was no risk for major surgery for all patients. None of the patients did not receive neoadjuvant radiotherapy and/or chemotherapy. Results: There were 87 (17.4%) patients in group 1 and 414 (82.6%) patients in group 2. The mean age was 73.3±3.01 (70-85) in group 1, and 58.3±7.47 (34-69) in group 2. There were no significantly difference between gender (0.135), pathological T stage (p=0.483), lymph node involvement (p=0.462), grade (p=0.522), type of diversion (p=0.193), histological type (p=0.656) in both groups. Perioperative mortality were 3.9% in group 1 and 3.4% in group 2 (p=0.218). Perioperative complication rates were 16.6 % in group 1 and 17.4% in group 2 (p=0.469). Five years disease specific survival (DSS) rates were 61% in group 1 and 53% in group 2 (p=0.936). The mean DSS periods were 72.91 ± 5.35 months in group 1 and 76.25±7.45 months in group 2. Five years overall survival rates were 43.9% in group 1, 45.9% in group 2 (p=0.476). Mean overall survival periods were 54.02±8.47 in group 1 and 69.25±4.97 in group 2. In cox regression analyse; tumor stage (p=0.012) and lymph node involvement (p<0.001) were significant factors affected the survival in both groups. Conclusions: We found similar oncological results in patients who underwent radical cystectomy because of bladder cancer between young and elderly patients. We believe that age is not a contraindication factor for radical cystectomy operation. In addition preoperative performance statue of patients is important in terms of perioperative complications and mortality.

Published in Clinical Medicine Research (Volume 3, Issue 6)
DOI 10.11648/j.cmr.20140306.19
Page(s) 206-210
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Bladder Cancer, Elderly, Radical Cystectomy

References
[1] Stroumbakis N, Herr HW, Cookson MS, Fair WR. Radical Cystectomy in the octogenarian. J Urol. 1997; 158 (6): 2113–7.
[2] Peyromaure M, Guerin F, Debre B, Zerbib M. Surgical management of infiltrating bladder cancer in elderly patients. Eur Urol. 2004; 45 (2): 147–54.
[3] Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009; 27(3): 289-93.
[4] Vaidya A, Soloway MS, Hawke C, Tiguert R, Civantos F. De novo muscle invasive bladder cancer: is there a change in trend? J Urol. 2001; 165(1): 47-50.
[5] J.A. Witjes (chair), E. Compérat, N.C. Cowan, M. De Santis, G. Gakis, T. Lebret et al. Guidelines on Muscle-invasive and Metastatic Bladder Cancer. European Association of Urology. 2013 p34.
[6] Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg. 2005; 131(1): 27-32.
[7] Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941; 2(3): 281–5.
[8] Jensen J, Pedersen K, Olsen K, Bisgaard U, Jensen K. Minilaparotomy approach to radical cystectomy. BJU Int. 2011; 108: 1125–1130.
[9] Chang SS, Alberts G, Cookson MS, Smith JA Jr. Radical cystectomy is safe in elderly patients at high risk. J Urol. 2001; 166(3): 938–41.
[10] Altekruse SF KC, Krapcho M, Neyman N, Animou R, Waldron W, Ruhl J, et al. SEER Cancer Statistics Review, 1975-2007. 2011
[11] Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5): 277–300.
[12] World Health Organization (WHO) Consensus Conference in Bladder Cancer, Hautmann RE, AbolEnein H, Hafez K, Haro I, Mansson W, Mills RD, Montie JD, Sagalowsky AI, Stein JP, Stenzl A, Studer UE, Volkmer BG. Urinary diversion. Urology 2007 Jan; 69(1 Suppl):17-49.
[13] Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001 Feb;19(3):666-75.
[14] Miller DC, Taub DA, Dunn RL, et al. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 2003 Jan;169(1):105-9.
[15] Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998 Apr;16(4):1582-7.
[16] Figueroa AJ, Stein JP, Dickinson M, et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 1998 Jul;83(1):141-7.
[17] Geriatric Assessment Methods for Clinical Decision making. NIH Consensus Statement Online 1987 Oct Online 19-21 [cited 2013 Feb, 6th];6(13):1-21
[18] Soulié M, Straub M, Gamé X, Seguin P, De Petriconi R, Plante P, et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol. 2002; 167(3): 1325–1328.
[19] Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, et al. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer. 2005; 104(1): 36–43.
[20] Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol. 2007; 51(3): 699–706.
[21] Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: An analysis data from the SEER program. J Urol. 2003; 170:1765–71.
[22] Dalbagni G, Genega E, Hashibe M, Zhang ZF, Russo P, Herr H et al. Cystectomy for bladder cancer: a contemporary series. J Urol. 2001; 165(4): 1111-6.
[23] Rosario DJ, Becker M, Anderson JB. The changing pattern of mortality and morbidity from radical cystectomy. BJU Int. 2000; 85(4): 427-30.
[24] Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19(3): 666-75.
[25] Liberman D, Lughezzani G, Sun M, Alasker A, Thuret R, Abdollah F et al. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology. 2011; 77(3): 660-6.
[26] Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol. 2007; 51(3): 699–708.
[27] Shariat SF, Milowsky M, Droller MJ. Bladder cancer in the elderly. Urol Oncol. 2009; 27(6): 653–67.
Cite This Article
  • APA Style

    Sacit Nuri Gorgel, Osman Kose, Ozan Horsanalı, Evren Sahin, Ugur Balci, et al. (2014). Radical Cystectomy in Elderly Patients, Single Center, 25 Years Experience. Clinical Medicine Research, 3(6), 206-210. https://doi.org/10.11648/j.cmr.20140306.19

    Copy | Download

    ACS Style

    Sacit Nuri Gorgel; Osman Kose; Ozan Horsanalı; Evren Sahin; Ugur Balci, et al. Radical Cystectomy in Elderly Patients, Single Center, 25 Years Experience. Clin. Med. Res. 2014, 3(6), 206-210. doi: 10.11648/j.cmr.20140306.19

    Copy | Download

    AMA Style

    Sacit Nuri Gorgel, Osman Kose, Ozan Horsanalı, Evren Sahin, Ugur Balci, et al. Radical Cystectomy in Elderly Patients, Single Center, 25 Years Experience. Clin Med Res. 2014;3(6):206-210. doi: 10.11648/j.cmr.20140306.19

    Copy | Download

  • @article{10.11648/j.cmr.20140306.19,
      author = {Sacit Nuri Gorgel and Osman Kose and Ozan Horsanalı and Evren Sahin and Ugur Balci and Kutan Ozer and Cengiz Girgin},
      title = {Radical Cystectomy in Elderly Patients, Single Center, 25 Years Experience},
      journal = {Clinical Medicine Research},
      volume = {3},
      number = {6},
      pages = {206-210},
      doi = {10.11648/j.cmr.20140306.19},
      url = {https://doi.org/10.11648/j.cmr.20140306.19},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20140306.19},
      abstract = {Objectives: To investigate the relation between age and tumor characteristics and to evaluate oncologic results after radical cystectomy in elderly patients. Materials and Methods: We reviewed 501 patients retrospectively who underwent radical cystectomy because of bladder cancer. Patients were divided into two groups; greater than or equal to 70 (group 1) and less than 70-years-old (group 2). We compared tumor pathological characteristics and oncologic results in both groups. American Society of Anesthesiologists (ASA) score is less than three and there was no risk for major surgery for all patients. None of the patients did not receive neoadjuvant radiotherapy and/or chemotherapy. Results: There were 87 (17.4%) patients in group 1 and 414 (82.6%) patients in group 2. The mean age was 73.3±3.01 (70-85) in group 1, and 58.3±7.47 (34-69) in group 2. There were no significantly difference between gender (0.135), pathological T stage (p=0.483), lymph node involvement (p=0.462), grade (p=0.522), type of diversion (p=0.193), histological type (p=0.656) in both groups. Perioperative mortality were 3.9% in group 1 and 3.4% in group 2 (p=0.218). Perioperative complication rates were 16.6 % in group 1 and 17.4% in group 2 (p=0.469). Five years disease specific survival (DSS) rates were 61% in group 1 and 53% in group 2 (p=0.936). The mean DSS periods were 72.91 ± 5.35 months in group 1 and 76.25±7.45 months in group 2. Five years overall survival rates were 43.9% in group 1, 45.9% in group 2 (p=0.476). Mean overall survival periods were 54.02±8.47 in group 1 and 69.25±4.97 in group 2. In cox regression analyse; tumor stage (p=0.012) and lymph node involvement (p<0.001) were significant factors affected the survival in both groups. Conclusions: We found similar oncological results in patients who underwent radical cystectomy because of bladder cancer between young and elderly patients. We believe that age is not a contraindication factor for radical cystectomy operation. In addition preoperative performance statue of patients is important in terms of perioperative complications and mortality.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Radical Cystectomy in Elderly Patients, Single Center, 25 Years Experience
    AU  - Sacit Nuri Gorgel
    AU  - Osman Kose
    AU  - Ozan Horsanalı
    AU  - Evren Sahin
    AU  - Ugur Balci
    AU  - Kutan Ozer
    AU  - Cengiz Girgin
    Y1  - 2014/12/31
    PY  - 2014
    N1  - https://doi.org/10.11648/j.cmr.20140306.19
    DO  - 10.11648/j.cmr.20140306.19
    T2  - Clinical Medicine Research
    JF  - Clinical Medicine Research
    JO  - Clinical Medicine Research
    SP  - 206
    EP  - 210
    PB  - Science Publishing Group
    SN  - 2326-9057
    UR  - https://doi.org/10.11648/j.cmr.20140306.19
    AB  - Objectives: To investigate the relation between age and tumor characteristics and to evaluate oncologic results after radical cystectomy in elderly patients. Materials and Methods: We reviewed 501 patients retrospectively who underwent radical cystectomy because of bladder cancer. Patients were divided into two groups; greater than or equal to 70 (group 1) and less than 70-years-old (group 2). We compared tumor pathological characteristics and oncologic results in both groups. American Society of Anesthesiologists (ASA) score is less than three and there was no risk for major surgery for all patients. None of the patients did not receive neoadjuvant radiotherapy and/or chemotherapy. Results: There were 87 (17.4%) patients in group 1 and 414 (82.6%) patients in group 2. The mean age was 73.3±3.01 (70-85) in group 1, and 58.3±7.47 (34-69) in group 2. There were no significantly difference between gender (0.135), pathological T stage (p=0.483), lymph node involvement (p=0.462), grade (p=0.522), type of diversion (p=0.193), histological type (p=0.656) in both groups. Perioperative mortality were 3.9% in group 1 and 3.4% in group 2 (p=0.218). Perioperative complication rates were 16.6 % in group 1 and 17.4% in group 2 (p=0.469). Five years disease specific survival (DSS) rates were 61% in group 1 and 53% in group 2 (p=0.936). The mean DSS periods were 72.91 ± 5.35 months in group 1 and 76.25±7.45 months in group 2. Five years overall survival rates were 43.9% in group 1, 45.9% in group 2 (p=0.476). Mean overall survival periods were 54.02±8.47 in group 1 and 69.25±4.97 in group 2. In cox regression analyse; tumor stage (p=0.012) and lymph node involvement (p<0.001) were significant factors affected the survival in both groups. Conclusions: We found similar oncological results in patients who underwent radical cystectomy because of bladder cancer between young and elderly patients. We believe that age is not a contraindication factor for radical cystectomy operation. In addition preoperative performance statue of patients is important in terms of perioperative complications and mortality.
    VL  - 3
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Izmir Katip Celebi University, Ataturk Training and Reseacrh Hospital, Department of Urology, Izmir, Turkey

  • Izmir Katip Celebi University, Ataturk Training and Reseacrh Hospital, Department of Urology, Izmir, Turkey

  • Izmir Katip Celebi University, Ataturk Training and Reseacrh Hospital, Department of Urology, Izmir, Turkey

  • Izmir Katip Celebi University, Ataturk Training and Reseacrh Hospital, Department of Urology, Izmir, Turkey

  • Izmir Katip Celebi University, Ataturk Training and Reseacrh Hospital, Department of Urology, Izmir, Turkey

  • Izmir Katip Celebi University, Ataturk Training and Reseacrh Hospital, Department of Urology, Izmir, Turkey

  • Sections